The Food and Drug Administration (FDA) will host a public workshop on virtual reality (VR) and augmented reality (AR) in medicine on March 5, 2020, at the FDA White Oak Campus in Silver Springs, Maryland.
The workshop, entitled “Medical Extended Reality: Toward Best Evaluation Practices for Virtual and Augmented Reality in Medicine” aims to discuss evaluation techniques for hardware, standards development, and assessment challenges for applications of Extended Reality (XR) in medicine. The goal is to identify critical gaps that may impede medical XR device development, innovation, and to advance the evaluation of medical XR devices and applications, thus accelerating the development of safe and effective medical XR devices, benefiting patients and healthcare.
The meeting will be webcasted live and the archived link will be posted on the FDA website for viewing after the workshop.